Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 18 of 18 for “"Fenretinide"”.
-
Fenretinide increases dihydroceramide and dihydrosphingolipids due to inhibition of dihydroceramide desaturase.
N-(4-Hydroxyphenyl) retinamide (4-HPR) is a derivative of all-trans-retinoic acid that induces apoptosis in cancer cell lines and is being tested in clinical trials as a relatively non-toxic anti-cancer agent. 4-HPR induces de novo sphingolipid biosynthesis and production of ceramide has been …
-
Mechanism(s) involved in the transport of Fenretinide across Caco-2 monolayers
… the possible reasons for poor oral absorption of fenretinide. Fenretinide was found to be highly lipophilic (log P = 7.4) and practically insoluble in water. The water solubility of fenretinide was enhanced by formulating it as a Povidone K 25 solid dispersion. The Transepithelial Electrical …
-
Investigation of the Effects of Genistein and Fenretinide on Ovarian Cancer Cells
The effects of the fenretinide and genistein as single or combined drugs on ovarian cancer proliferation and viability were investigated. Hypothesis: Co-treatment with genistein will enable a lower dose of fenretinide to be effective in inhibiting the proliferation and survival of ovarian cancer …
-
Pharmacologic modulation of fenretinide metabolism and cytotoxic mechanisms of an active metabolite in human lymphoid malignancies
Fenretinide (N-(4-hydroxyphenyl)retinamide; 4-HPR) is a synthetic retinoid that is reported to be cytotoxic to, or inhibit the growth of, tumor cell lines and/or xenografts of various cancer types at concentrations of 1 – 10 μM. 4-HPR has also been studied clinically in phase I, II, and III …
-
Fenretinide sensitizes multidrug-resistant human neuroblastoma cells to antibody-independent and ch14.18-mediated NK cell cytotoxicity
… ADCC). We demonstrate that pre- treatment of fenretinide-resistant NB cells with 4-HPR significantly enhanced ch14.18-mediated CDC and ADCC as well as AICC by both human NK cells and PBMCs. Interestingly, we also found an increase of the GD2 binding index and an increase of DRs in all cell …
-
Design, synthesis and biological evaluation of retinoid and non-retinoid mimetics of fenretinide as chemotherapeutic agents
Fenretinide is a potent chemotherapeutic and chemopreventive against a range of cancer tumour cell lines, namely Ewing’s Sarcoma Family of Tumours (ESFT) which is an aggressive malignant tumour primarily affecting children and young adults. The mechanism of action of the drug is not known. The …
-
The Modulation of Retinol and Lipid Binding Proteins to enhance cell death in Ewing’s Sarcoma Family of Tumours
… more effective treatments with minimal toxicity. Fenretinide is a chemotherapeutic that has cytotoxic effects in several cancers, making it an attractive potential therapeutic. However, its use in clinical practice has been limited by poor solubility and bioavailability. I have hypothesised that …
-
SPHINGOLIPID METABOLISM'S ALTERATIONS CORRELATED WITH TUMOR CELL INVASIVITY AND FENRETINIDE RESISTANCE IN A HUMAN OVARIAN CARCINOMA CELL LINE
… retinoid N-(4-hydroxyphenyl)retinamide (fenretinide or HPR), that is currently it is under clinical trials as preventive chemotherapeutic drug for prostatic and ovarian cancer, neuroblastoma, lymphoma and leukemia. A2780/HPR is a HPR-resistant cell line obtained from the parental A2780 …
-
Food Protein-based Core-shell Nanocarriers for Oral Drug Delivery Applications: (Influence of Shell Composition on <em>In vitro</em> and <em>In vivo</em> Functional Performance of Zein Nanocarriers
… core-shell nanocarriers for oral delivery of fenretinide, an investigational anti-cancer molecule. Fenretinide has been found to be effective against several cancers including pediatric neuroblastoma, However, the clinical development of fenretinide is limited by its poor physicochemical …
-
Targeting BCL-2 Family Members in the Cell Death Pathway to Treat Head and Neck Cancer
… NOXA induced by adenovirus (Ad-NOXA) or fenretinide inactivates anti-apoptotic MCL-1, while ABT-263 can inactivate other anti-apoptotic BCL-2 family members such as BCL-2 and BCL-XL. We used p53 inactive HN8 and HN12, p53 wild-type UMSCC1, and HPV-positive UMSCC47 human HNSCC cell lines …
-
Novel therapies for diffuse intrinsic pontine glioma
… report to highlight the cytotoxic activity of fenretinide against DIPG cells. Fenretinide was effective in vitro across a panel of DIPG cell lines. Our DIPG cell lines were characterized by the absence of retinoic acid receptor expression which may explain the lack of activity of other …
-
Localized Transdermal Delivery of Chemopreventive Agents to the Breast
… were used. This includes aspirin, endoxifen and fenretinide. Due to the systemic side effects and/or poor oral bioavailability of these chemopreventive agents, they were selected in the current work. To explore the feasibility of localized transdermal delivery of these agents to the breast …
-
Combining Noxa-Inducing Drugs with ABT-263 to Efficiently Increase Cell Death in Head and Neck Squamous Cell Carcinoma (HNSCC)
… use three clinically-available drugs: cisplatin, fenretinide, and ABT-263 (navitoclax). Both cisplatin and fenretinide are known to induce a BH3-only pro-apoptotic protein, Noxa, which binds to and inactivates multi-domain anti-apoptotic protein MCL-1 and release from its interaction with …
-
RETINOID-INDUCED APOPTOSIS AND PROLIFERATION OF HEPATOCYTES ARE MEDIATED BY DISTINCT NUCLEAR RECEPTORS
… to the apoptotic effect of a synthetic retinoid, fenretinide. The findings establish a role for the nuclear receptors RARβ; and Nur77 in mediating fenretinide effect. The second part of this dissertation investigates the mechanism responsible for 13-cis retinoic acid-induced liver cell …
-
Participation of de novo sphingolipid biosynthesis in the regulation of autophagy in response to diverse agents
… It also analyzes the structural properties of fenretinide that contribute to its ability to modulate sphingolipid metabolism through inhibition of dihydroceramide desaturase, thereby elevating dihydroceramide and induction of autophagy. Autophagy was monitored by following the redistribution of …
-
C22:0- and C24:0-dihydroceramides confer cytotoxicity in T-cell acute lymphoblastic leukemia cell lines
… retinoid N-(4-hydroxyphenyl)-retinamide (fenretinide, 4-HPR) is an anti-cancer agent under clinical evaluation in a variety of cancers, including in pediatric acute lymphoblastic leukemia (ALL). We have previously reported that 4-HPR induces cell death in association with an increase of …
-
Targeting EWS/FLI1 activity in ewing sarcoma
… of 9 well known drugs such as camptothecin, fenretinide, etoposide and doxorubicin, we also identified the kinase inhibitor midostaurin (PKC412). Subsequent experiments demonstrated that midostaurin is able to induce apoptosis in a panel of 6 ES cell lines in vitro and can significantly …
-
The role of sphingosine kinases and dihydroceramide desaturase in cell survival/apoptosis and inflammation pathways
… or the Degs1 inhibitor fenretinide promoted the polyubiquitination of Degs1 (Mr = 40-140 kDa) through a mechanism involving p38 mitogen-activated protein kinase (MAPK), oxidative stress, and Mdm2 (E3 ligase) in HEK293T cells.;The polyubiquitinated forms of Degs1 acquire a …